Sign in

CIK 0001559053

  • Accelerated filer

PROTHENA CORP PUBLIC LTD CO

Sign in to watch
Ticker
PRTA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Ireland
Entity type
Operating
Phone
+353 12362500
Business address
77 SIR JOHN ROGERSON'S QUAY, BLOCK C, GRAND CANAL DOCKLANDS, DUBLIN 2, Ireland, D02 VK60
Former names
Prothena Corp plc, Neotope Corp Ltd
Open-market buys, last 90 days
$9,848,721
in 10 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$9,848,721. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. SCULLY WILLIAM P +$9.8M 10% owner 10 filings

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-03-15 Malecek Michael J Chief Legal Officer Sale −8,564 $48.67 $417K 0
2023-03-15 Malecek Michael J Chief Legal Officer Option exercise · Stock Option (Right to Buy) −15,000 125,000
2023-03-15 Garren Hideki Chief Medical Officer Option exercise +12,000 $24.90 $299K 12,000
2023-03-15 Garren Hideki Chief Medical Officer Sale −6,000 $48.16 $289K 6,000
2023-03-15 Garren Hideki Chief Medical Officer Sale −6,000 $48.66 $292K 0
2023-03-15 Garren Hideki Chief Medical Officer Option exercise · Stock Option (Right to Buy) −12,000 210,000
2023-03-02 Malecek Michael J Chief Legal Officer Grant or award · Stock Option (Right to Buy) +48,000 48,000
2023-03-02 Karp Carol D. Chief Regulatory Officer Grant or award · Stock Option (Right to Buy) +48,000 48,000
2023-03-02 Smith Brandon S. Chief Operating Officer Grant or award · Stock Option (Right to Buy) +48,000 48,000
2023-03-02 Zago Wagner M. Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +48,000 48,000
2023-03-02 Nguyen Tran Chief Strategy Officer and CFO Grant or award · Stock Option (Right to Buy) +48,000 48,000
2023-03-02 Garren Hideki Chief Medical Officer Grant or award · Stock Option (Right to Buy) +48,000 48,000
2023-03-02 Kinney Gene G. President and CEO Grant or award · Stock Option (Right to Buy) +155,000 155,000
2023-03-02 Walker Karin L Chief Accounting Officer Grant or award · Stock Option (Right to Buy) +38,000 38,000
2023-02-15 Nguyen Tran Chief Strategy Officer and CFO Option exercise +10,000 $6.73 $67K 13,200
2023-02-15 Nguyen Tran Chief Strategy Officer and CFO Sale −9,336 $53.30 $498K 3,864
2023-02-15 Nguyen Tran Chief Strategy Officer and CFO Sale −664 $53.87 $36K 3,200
2023-02-15 Nguyen Tran Chief Strategy Officer and CFO Option exercise · Stock Option (Right to Buy) −10,000 10,000
2023-01-18 Nguyen Tran Chief Strategy Officer and CFO Option exercise +10,000 $6.73 $67K 13,200
2023-01-18 Nguyen Tran Chief Strategy Officer and CFO Sale −7,277 $55.18 $402K 5,923

Page 17 of 28 · 555 trades